Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis

We report a case of myasthenia gravis, myocarditis, and myositis following the treatment of melanoma with nivolumab. The patient was a 68-year-old Caucasian male with stage 3 melanoma status after two doses of nivolumab with shortness of breath, intermittent palpitations, dizziness, and nausea. Duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bawek, Sawyer J, Ton, Ryan, McGovern-Poore, Margaret, Khoncarly, Bilal, Narvel, Ravish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520605/
https://www.ncbi.nlm.nih.gov/pubmed/34671527
http://dx.doi.org/10.7759/cureus.18040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520605/
https://www.ncbi.nlm.nih.gov/pubmed/34671527
http://dx.doi.org/10.7759/cureus.18040

Ejemplares similares